The role of long chain omega-3 polyunsaturated fatty acids (fish oil) on weight management
Not Applicable
Completed
- Conditions
- obesityDiet and Nutrition - Obesity
- Registration Number
- ACTRN12610000659000
- Lead Sponsor
- The University of Newcastle
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Body Mass Index (BMI) between 30 and 40. Can consume fish. Can swallow capsules
Exclusion Criteria
BMI >40; Diabetic; Already consuming fish oil capsules or 2 or more oily fish meals/week; Has an inflammatory condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of % change in total body fat from baseline between groups using bioelectrical impedance.[At baseline, at 12 weeks, at 22 weeks];Comparison of % change in fat free mass from baseline between groups using bioelectrical impedance assessment[At baseline, at 12 weeks, at 22 weeks];Comparison of % change in weight from baseline between groups using a calibrated balance beam scale to measure weight[At baseline, at 12 weeks, at 22 weeks]
- Secondary Outcome Measures
Name Time Method Comparison of changes in inflammatory biomarkers from baseline between groups using commerically available Enzyme Linked ImmunoSorbent Assays (ELISAs), namely Leptin, Adiponectin, Interleukin-6 (IL-6), Tumour Necrosis Factor alpha (TNFa) and Leukotriene B4 (LTB4). Also C-Reactive Protein which will be analysed by Hunter Area Pathology Services.[At baseline, at 12 weeks, at 22 weeks];Comparison of changes in blood glucose and blood lipids from baseline between groups. Fasting blood glucose and blood lipids will be analysed by Hunter Area Pathology Services.[At baseline, at 12 weeks, at 22 weeks];Comparison of changes in plasma fatty acids between groups. Plasma fatty acid profiles will be determined using Gas Chromatography analysis.[At baseline, at 12 weeks, at 22 weeks]